Zidovudine
Composition
The formulation contains Each tablet contains Zidovudine 300 mg as the active ingredient.
Indications
The use of this drug is indicated in the treatment of HIV-1 infection.
Side effects
Mild to moderate side effects have been observed such as headache, nausea, vomiting, and myelosuppression.
Precautions
To be used with caution in patients with hepatic impairment and a history of hematologic disorders.
Contraindications
This drug is contraindicated in patients with a known hypersensitivity reaction to Zidovudine.
Dosage and administration
The recommended dosage is 300 mg orally twice daily.
Countries
We have established our roots in other countries as well, such as United Kingdom, South Korea, Egypt, and Turkey.
Available Forms
Tablets, oral solutions
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai